Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
Department of Health and Human Services
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent o
Funding
Award size
$100K – $1M
Award ceiling
150000
Type
Grant
Dates
Deadline
Later
Posted
12/30/2024
Closes
2027-08-11
Eligibility
Eligibility
Public and State controlled institutions of higher educationNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationCity or township governmentsSpecial district governmentsNative American tribal organizations (other than Federally recognized tribal governments)County governmentsNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationState governmentsFor profit organizations other than small businessesIndependent school districtsSmall businessesOthers (see text field entitled "Additional Information on Eligibility" for clarification)Public housing authorities/Indian housing authoritiesNative American tribal governments (Federally recognized)Private institutions of higher education
Program
Funding area
Education - EDHealth - HL
Opportunity #
PAR-25-101
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov